biomedicina slovenica

pr=Čufer : 82-181

  1. Strojnik Ksenija; Pajk Bojana; Čufer Tanja
    Neutropenia in breast cancer patients treated with neo/adjuvant chemotherapy containing docetaxel and/or epidoxorubicin
    2007 ►
  2. Knez Lea; Sadikov Aleksander; Jakelj Andraž; Mohorčič Katja; Turnšek Nina; Čufer Tanja
    Overall survival in advanced lung cancer patients proposed initial chemotherapy according to actual chemotherapy delivery
    2015 ►
  3. Globočnik Kukovica Marta; Mohorčič Katja; Sadikov Aleksander; Jakelj Andraž; Čufer Tanja
    Survival of lung cancer patients involved or not into early palliative care setting
    2015 ►
  4. Janžič Urška; Kern Izidor; Čavka Luka; Janžič Andrej; Čufer Tanja
    PD-L1 expression in NSCLC
    2015 ►
  5. Turnšek Nina; Kern Izidor; Sadikov Aleksander; Rot Mitja; Stanič Karmen; Zwitter Matjaž; Čufer Tanja
    Immunohistochemically determined EGFR mutations and selection of patients for EGFR-directed therapy in NSCLC
    2015 ►
  6. Čufer Tanja; Knez Lea
    Pristop k povečanju varnosti sistemskega zdravljenja raka
    2015 ►
  7. Čufer Tanja
    December 2006 San Antonio meeting
    2007 ►
  8. Pajk Bojana; Čufer Tanja
    Current role of ovarien ablation in the treatment of pre-menopausal women with breast cancer
    2006 ►
  9. Režonja Renata; Grabnar Iztok; Mrhar Aleš; Čebron Lipovec Nanča; Čufer Tanja; Vovk Tomaž
    A simple dried blood spot method for clinical pharmacological analyses of etoposide in cancer patients using liquid chromatography and fluorescence detection
    2015 ►
  10. Koren Ana; Rijavec Matija; Kern Izidor; Sodja Eva; Korošec Peter; Čufer Tanja
    BMI1, ALDH1A1, and CD133 transcripts connect epithelial-mesenchymal transition to cancer stem cells in lung carcinoma
    2015 ►
  11. Čufer Tanja
    Letno srečanje ASCO
    2015 ►
  12. Čufer Tanja
    Zagotavljanje varnosti bolnikov pri dolgotrajnem sistemskem zdravljenju raka
    2012 ►
  13. Čufer Tanja; Knez Lea
    Tarčna terapija in imunoterapija pljučnega raka
    2015 ►
  14. Čufer Tanja; Pajk Bojana
    Zagotavljanje varnosti bolnikov na sistemskem zdravljenju raka
    2008 ►
  15. Ramlau Rodryg; Čufer Tanja; Kern Izidor
    Epidermal growth factor receptor mutation-positive non-small-cell lung cancer in the real-world setting in Central Europe
    2015 ►
  16. O'Brien Mary E. R.; Gaafar Rabab; Hasan Baktiar; Menis Jessica; Čufer Tanja; Popat Sanjay; Woll Penella J.; Surmont Veerle; Georgoulias Vassilis; Montes Ana; Blackhall Fiona; Hennig Ivo; Schmid-Bindert Gerald; Baas Paul
    Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy
    2015 ►
  17. Koren Ana; Sodja Eva; Rijavec Matija; Jež Mojca; Kovač Viljem; Korošec Peter; Čufer Tanja
    Prognostic value of cytokeratin-7 mRNA expression in peripheral whole blood of advanced lung adenocarcinoma patients
    2015 ►
  18. Čufer Tanja
    Individualized systemic therapy of non-small cell lung cancer
    2013 ►
  19. Čufer Tanja
    Individualized, biomarker driven systemic therapy of lung cancer
    2013 ►
  20. Janžič Urška; Čufer Tanja; Turnšek Nina; Janžič Andrej
    Age as independant predictive factor for EGFR mutation status
    2013 ►
  21. Čufer Tanja
    Supportive and symptomatic care of lung cancer patients on systemic therapy
    2012 ►
  22. Čufer Miha; Selič Polona
    Bolnikova ocena zaupanja zdravniku družinske medicine z vidika zdravnikove urejenosti
    2015 ►
  23. Gourgou-Bourgade Sophie; Čufer Tanja
    Guidelines for time-to-event end point definitions in breast cancer trials
    2015 ►
  24. Čufer Tanja; Knez Lea
    Update on systemic therapy of advanced non-small-cell lung cancer
    2014 ►
  25. Bonnefoi Herve; Čufer Tanja
    Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes
    2014 ►
  26. Čufer Tanja
    Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality
    2014 ►
  27. Turnšek Nina; Kern Izidor; Sadikov Aleksander; Rot Mitja; Stanič Karmen; Zwitter Matjaž; Čufer Tanja
    Immunohistochemically determined EGFR mutations in NSCLC
    2014 ►
  28. Efficace Fabio; Biganzoli Laura; Piccart Martine; Čufer Tanja
    Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer
    2004 ►
  29. Čufer Tanja; Kmetec Andrej; Kragelj Borut; Oblak Ciril; Sedmak Boris; Tršinar Bojan; Oblak Ciril; Zakotnik Branko
    Smernice za zdravljenje raka prostate
    2008 ►
  30. Čufer Tanja; Borštnar Simona
    Zdravljenje hormonsko neodzivnega raka prostate
    2008 ►
  31. Čufer Tanja
    5. evropska konferenca o raku dojk
    2006 ►
  32. Sajko Špela; Čufer Tanja; Meško-Brguljan Pika
    An interdisciplinary audit of tumor marker utilization in the University Clinic Golnik
    2012 ►
  33. Knez Lea; Jošt Maja; Toni Janez; Triler Nada; Čufer Tanja
    Uvajanje novih farmacevtskih storitev ob prehodu na centralizirano pripravo protitumornih zdravil
    2014 ►
  34. Sodja Eva; Rijavec Matija; Koren Ana; Kern Izidor; Korošec Peter; Čufer Tanja
    SOX2 gene expression and copy number variation in squamous cell lung cancer
    2014 ►
  35. Sodja Eva; Rijavec Matija; Koren Ana; Sadikov Aleksander; Korošec Peter; Čufer Tanja
    The impact of SOX2, NANOG and OCT4 mRNA expression levels in whole blood on prognosis of advanced small-cell lung cancer patients
    2014 ►
  36. Koren Ana; Sodja Eva; Rijavec Matija; Sadikov Aleksander; Korošec Peter; Čufer Tanja
    Bmi1 mRNA expression in non-small cell lung cancer is decreased and may represent a new blood biomarker for survival of advanced disease
    2014 ►
  37. Čufer Tanja; Švajger Sanja
    Izzivi pri komunikaciji med bolnikom in zdravnikom onkologom
    2007 ►
  38. Čufer Tanja; Košnik Mitja
    Klinični register bolnikov z rakom pljuč
    2013 ►
  39. Čufer Tanja; Turnšek Nina
    Adjuvantno in neoadjuvantno zdravljenje operabilnega nedrobnoceličnega raka pljuč
    2014 ►
  40. Čufer Tanja
    Systemic therapy of NSCLC
    2014 ►
  41. Čufer Tanja
    Adjuvant / Neo-adjuvant systemic therapy of operable NSCLC
    2014 ►
  42. Čufer Tanja
    Systemic treatment of HER2-positive disease
    2014 ►
  43. Mohorčič Katja; Turnšek Nina; Globočnik Marta; Sadikov Aleksander; Čufer Tanja
    Efficacy and safety of pemetrexed combined with platinum in the treatment of advanced nonsquamous NSCLC in A routine clinical practice
    2014 ►
  44. Unk Mojca; Pahole Goličnik Jana; Čufer Tanja
    Slovenian data on compassionate use program (CUP) of afatinib (A) in patients (PTS) pretreated with gefitinib (G) or erlotinib (E)
    2014 ►
  45. Turnšek Nina; Sadikov Aleksander; Čufer Tanja
    Efficacy and safety of EGFR TKIS in EGFR-mutated advanced NSCLC
    2014 ►
  46. Knez Lea; Kerec Kos Mojca; Čufer Tanja
    Drug interactions in cancer treatment
    2014 ►
  47. Strojnik Ksenija; Humar Mojca; Čufer Tanja
    Rak dojk
    2008 ►
  48. Čufer Tanja; Zakotnik Branko; Ocvirk Janja; Jezeršek Novaković Barbara; Matos Erika
    Tarčna zdravila v onkologiji
    2008 ►
  49. Costa A; Čufer Tanja
    ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
    2014 ►
  50. Trobec Katja; Knez Lea; Meško-Brguljan Pika; Čufer Tanja; Lainščak Mitja
    Ocena ledvične funkcije pri bolnikih s pljučnim rakom
    2014 ►
  51. Šeruga Boštjan; Zadnik Vesna; Grašič-Kuhar Cvetka; Marinko Tanja; Čufer Tanja; Zakotnik Branko; Zorman Darko; Ocaña Alberto; Amir Eitan
    Association of aromatase inhibitors with coronary heart disease in women with early breast cancer
    2014 ►
  52. Shepherd Frances A.; Douillard Jean-Yves; Fukuoka Masahiro; Saijo Nagahiro; Kim Sang-We; Čufer Tanja; Sellers Mark V.; Armour Alison A.; Kim Edwards S.
    Gefitinib versus docetaxel in patients with pretreated advanced non-small-cell lung cancer (NSCLC)
    2009 ►
  53. Čufer Tanja
    Tarčna zdravila za raka pljuč ali kako pri bolnikih z nedrobnoceličnim rakom pljuč z molekularnimi preiskavami določimo dovzetnost tumorja za tarčno zdravilo
    2013 ►
  54. Čufer Tanja
    Sledenje bolnikov z rakom
    2013 ►
  55. Čufer Tanja; Bošnjak Dragica
    Se trdoživost rakavih celic skriva v darvinizmu?
    2014 ►
  56. Čufer Tanja; Blejc Urša
    Tretjini bolnic bo kemoterapija prihranjena
    2008 ►
  57. Čufer Tanja; Senčar Mojca; Zorko Danica
    Kaj je Herceptin
    2008 ►
  58. Čufer Tanja; Železnik Neva
    Tarčna zdravila
    2007 ►
  59. Čufer Tanja
    Tarčno zdravljenje nedrobnoceličnega raka pljuč
    2014 ►
  60. Ribi K.; Čufer Tanja
    Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
    2012 ►
  61. Čufer Tanja
    Systemic therapy beyond progression on first-generation TKIs in EGFR mutated non-small cell lung cancer
    2014 ►
  62. Čufer Tanja
    Update on systemic therapy of non-small cell lung cancer
    2014 ►
  63. Šeruga Boštjan; Zadnik Vesna; Grašič-Kuhar Cvetka; Marinko Tanja; Zorman Darko; Čufer Tanja; Zakotnik Branko; Ocaña Alberto; Amir Eitan
    Aromatase inhibitors and cardiac outcomes in women undergoing cardiac angiography after early breast cancer
    2012 ►
  64. Humar Mojca; Čufer Tanja
    Anemija pri bolnikih z rakom
    2013 ►
  65. Šeruga Boštjan; Sadikov Aleksander; Cazap Eduardo L.; Delgado Lucia Beatriz; Digumarti Raghunadharao; Leighl Natasha B.; Meshref Mohamed M.; Minami Hironobu; Robinson Eliezer; Yamaguchi Nise Hitomi; Pyle Doug; Čufer Tanja
    Barriers and challenges to global clinical cancer research.
    2014 ►
  66. Knez Lea; Čufer Tanja
    Drug interactions in cancer treatment
    2013 ►
  67. Čufer Tanja; O'Brien Mary E. R.
    The PARAMOUNT study and the re-challenge chemotherapy issue in advanced non-small cell lung cancer
    2013 ►
  68. Buturović-Ponikvar Jadranka; Gubenšek Jakob; Arnol Miha; Likar Cvetka; Adamlje Tone; Blanuša Danica; Ceglar Zlata; Cimerman-Steklasa Sonja; Černe Senka; Čufer Andrej; Drozg Andrej; Ekart Robert; Guček Andrej; Kandus Aljoša; Kapun Sonja; Kralj Stojan; Kralj Lopert Simona; Kunc Rešek N.; Malovrh Marko; Močivnik Marijan; Novljan Gregor; Ponikvar Rafael; Rus Igor; Saksida Silvana; Vujkovac Bojan
    Renal replacement therapy in Slovenia
    2013 ►
  69. Buturović-Ponikvar Jadranka; Škrjanc Andreja; Gubenšek Jakob; Arnol Miha; Adamlje Tone; Blanuša Danica; Ceglar Zlata; Černe Senka; Čufer Andrej; Drozg Andrej; Ekart Robert; Globokar Mateja; Kandus Aljoša; Kapun Sonja; Kralj Lopert Simona; Kralj Stojan; Kunc Rešek N.; Malovrh Marko; Močivnik Marjan; Ponikvar Rafael; Rus Igor; Saksida Silvana; Vujkovac Bojan
    Long term (>30 years) renal replacement therapy survivors in Slovenia
    2013 ►
  70. Kolar Maja; Čufer Tomaž; Pintar Marina
    Učinek dodatka zeolitnih delcev v rastne substrate na rast pelargonij (Pelargonium zonale L.)
    [#The #effect of the addition of the natural zeolite into growing media on the growth of Pelargoniums (Pelargonium zonale L.)]
    2013 ►
  71. Ovčariček Tanja; Čufer Tanja; Kern Izidor; Sodja Eva; Sadikov Aleksander
    Efficacy of tyrosine kinase inhibitors inroutine clinical practice
    2013 ►
  72. Knez Lea; Sodja Eva; Kern Izidor; Ovčariček Tanja; Sadikov Aleksander; Košnik Martina; Čufer Tanja
    Evaluation of the predictive value of ABCB1, ABCC1 and MVP in small cell lung cancer
    2013 ►
  73. Harbeck Nadia; Čufer Tanja; Borštnar Simona
    Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients
    2013 ►
  74. Čufer Tanja; Šeruga Boštjan
    Global survey on barriers to clinical cancer research
    2012 ►
  75. Čufer Tanja; Kovač Viljem
    Prodirajo tarčna zdravila v kombinacijah s kemoterapijo
    2012 ►
  76. Buturović-Ponikvar Jadranka; Gubenšek Jakob; Arnol Miha; Adamlje Tone; Blanuša Danica; Ceglar Zlata; Cimerman-Steklasa Sonja; Černe Senka; Čufer Andrej; Drozg Andrej; Ekart Robert; Guček Andrej; Kandus Aljoša; Kapun Sonja; Kralj Lopert Simona; Klančič Dimitrij; Kunc Rešek N.; Kralj Stojan; Malovrh Marko; Močivnik Marjan; Novljan Gregor; Ponikvar Rafael; Rus Igor; Saksida Silvana; Vujkovac Bojan
    Renal replacement therapy in Slovenia
    2013 ►
  77. Čufer Tanja; Ovčariček Tanja; O'Brien Mary E. R.
    Systemic therapy of advanced non-small cell lung cancer
    2013 ►
  78. Režonja Renata; Knez Lea; Čufer Tanja; Mrhar Aleš
    Oral treatment with etoposide in small cell lung cancer - dilemmas and solution
    2013 ►
  79. Čufer Tanja; Šeruga Boštjan
    Ovire in izzivi v kliničnem raziskovanju v onkologiji
    2013 ►
  80. Čufer Tanja; Košnik Mitja
    Klinični register bolnikov z rakom pljuč
    2013 ►
  81. Turnšek-Hitij Nina; Mohorčič Katja; Sadikov Aleksander; Čufer Tanja
    Neutropenia in lung cancer patients treated with chemotherapy in a routine clinical practice - an institutional experience
    2012 ►
  82. Sodja Eva; Rijavec Matija; Korošec Peter; Koren Ana; Čufer Tanja
    Expression of stem cell markers SOX2, NANOG and OCT4 in whole blood samples of lung cancer patients
    2012 ►
  83. Ovčariček Tanja; Unk Mojca; Kern Izidor; Čufer Tanja
    EGFR exon 20 insertion mutations in patients with non-small cell lung cancer treated in Slovenia
    2012 ►
  84. Čufer Tanja
    Konzilijarni list
    2012 ►
  85. Čufer Tanja; Kadivec Saša
    Predstavitev Enote za internistično onkologijo in njena umestitev v multidisciplinarno obravnavo raka
    2012 ►
  86. Šeruga Boštjan; Novak Šarotar Brigita; Knez Lea; Borštnar Simona; Janša Rado; Kocmur Marga; Čufer Tanja
    Sočasno zdravljenje s tamoksifenom in z zaviralci CYP2D6: klinični pomen interakcij zdravil
    [Concurrent treatment with tamoxifen and CYP2D6 inhibitors: clinical significance of drug interactions]
    2012 ►
  87. Čufer Tanja
    Draga zdravila da, a s čim manj škode za bolnika in družbo
    2012 ►
  88. Sodja Eva; Knez Lea; Kern Izidor; Ovčariček Tanja; Sadikov Aleksander; Čufer Tanja
    Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy
    2012 ►
  89. Cazap Eduardo L; Čufer Tanja
    Perspectives on the high-level meeting on non-communicable diseases
    2012 ►
  90. Čufer Tanja; Košnik Mitja
    Ustanovitev enote za internistično onkologijo na Kliniki Golnik
    2012 ►
  91. Ovčariček T; Unk M; Kern I; Čufer T
    EGFR exon 20 insertion mutations in NSCLC: frequency and treatment outcomes with EGFR directed TKIs
    2012 ►
  92. Knez L; Košnik M; Ovčariček T; Sadikov A; Sodja E; Kern I; Čufer T
    Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy
    2012 ►
  93. Čufer Tanja
    Aktivnosti največjega mednarodnega strokovnega združenja onkologov ASCO in pogled na srečanje ASCO 2011
    2011 ►
  94. Čufer Tanja
    Razvoj tarčnih zdravil za raka
    [Developing targeted therapy for cancer]
    2012 ►
  95. Cardoso F; Costa A; Norton L; Cameron D; Čufer T; Fallowfield L; Francis P; Gligorov J; Kyriakides S; Lin N
    1st International consensus guidelines for advanced breast cancer (ABC 1)
    2012 ►
  96. Čufer Tanja
    Aktivnosti največja mednarodnega strokovnega združenja onkologov ASCO in pogled na srečanje ASCO 2011
    2011 ►
  97. Čufer Tanja; Ovčariček Tanja; Kern Izidor
    Pomen mutacije gena receptorja za epidermalni rastni dejavnik za zdravljenje nedrobnoceličnega raka pljuč
    2011 ►
  98. Lekič Mirko; Kovač Viljem; Triller Nadja; Knez Lea; Sadikov Aleksander; Čufer Tanja
    Outcome of small cell lung cancner (SCLC) patients with brain metastases in a routine clinical setting
    [Analiza bolnikov z drobnoceličnim rakom pljuč in možganskimi zasevki v klinični praksi]
    2012 ►
  99. Davies C; Godwin J; Gray R; Čufer T
    Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
    2011 ►
  100. Regan Meredith; Neven Patrick; Giobbie-Hurder Anita; Čufer T
    Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8-1 years median follow-up
    2011 ►

   1 82 182 282 382 482  

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics